Thyroid peroxidase (TPO) is the key enzyme in the synthesis ofthyroid hormones, and the TPO defects are believed to be the most prevalent causes of the inborn errors of thyroid metabolism. We investigated an adopted boy with iodide organification defect, who presented with florid hypothyroidism at the age of4 mo, poorly complied with thyroxine treatment, and developed a compressive goiter necessitating partial resection at the age of 12 yr.
Introduction
Congenital hypothyroidism is a public health concern affecting 1/4,000 births. Although most cases result from dysembryogenesis of the thyroid gland, an interesting minority are due to inborn errors ofthyroid hormones metabolism ( 1 ) . Congenital goiters due to defective synthesis ofthyroid prohormone thyroglobulin (TG)' have been investigated in man and in animal models (1) (2) (3) (4) , and a pathogenic mutation has recently been identified in the human (5); however, the most prevalent cause of inherited defects in thyroid metabolism is believed to be the thyroid peroxidase (TPO) deficiency (6) .
TPO is the key enzyme in thyroid hormones formation; it catalyzes both the iodination and the coupling of hormonogenic tyrosyl residues of TG (7, 8) . TPO is a 1 10-kD glycopro-tein, using heme as a cofactor, whose primary structure has been deduced from the sequence ofthe cloned complementary DNA (cDNA) (9-1 1). Sequences involved in the enzymatic mechanism have been postulated by comparison with related peroxidase enzymes (12) . The TPO gene, located on chromosome 2 [2pter-2p24] (10, 13) consists of 17 exons and 16 introns ( 14) .
Congenital TPO defects, typically transmitted as autosomal recessive traits, result in hypothyroid goiters with failure to convert iodide into organic iodine (organification defect) (8) . Genetic heterogeneity is expected in this syndrome, as it may result from several mechanisms ( 1), including total absence of TPO activity, inability of TPO to bind to the heme cofactor ( 15) , inability to interact with the TG substrate, and abnormal subcellular localization (8) . Recent linkage studies supported heterogeneity of the mutations involved, and suggested that one pathogenic TPO mutation might consist ofa not yet identified partial genomic deletion (6) .
In the present study, we have identified a human mutation causing TPO deficiency. It consists of a duplication ofa tetranucleotide -GGCC-in exon 8 of the TPO gene occurring in a homozygous subject presenting with congenital goiter and hypothyroidism. The resulting frameshift generates stop codons in exon 9, which would result in a grossly truncated protein with no expected activity.
Methods
Patient. D.M., a 4-mo-old adopted male, was referred to the endocrine service (Centro de Investigationes Endocrinologicas, CONICET, Hospital de niftos "Ricardo Gutierrez," Buenos Aires, Argentina), where a diagnosis of hypothyroidism was made. The serum thyroxine (14) level was 0.1 tg/dl (normal, [5] [6] [7] [8] [9] [10] [11] [12] [13] Ag/dl) and the patient was immediately given thyroid hormone therapy. At the age of 5 yr the physical examination showed moderate to severe mental retardation with speech difficulties and stunted growth. The medication was discontinued and laboratory testing revealed: low serum triiodothyronine (T3) (25 ng/dl, normal 100-200 ng/ml) and T4 ( 1.6 ,g/dl), elevated thyrotropin (> 80 uUU/ml, normal < 9 AU/ml) and a positive thiocyanate discharge test (27% discharge of labeled iodine, normal < 10% 5'tggaagcttgcgtccagcctcctcacc3'). Standard PCR conditions were the following: 1 min at 930C, 2 min at 550C, 3 min at 720C, X35 cycles, in 100-,ul reaction volumes with 1.5 mM MgCl2 and 10% DMSO. The PCR product was visualized by electrophoresis in a 2% agarose gel followed by ethidium bromide staining, and aliquots were cloned in M13 mpl8 and mpl9 and sequenced on both strands (model 370A DNA sequencer, Applied Biosystems, Inc., Foster City, CA).
A 460-bp genomic DNA fragment containing the exon 8/intron 8 junction was amplified under identical conditions from goiter DNA using the same forward primer complementary to exon 8 (1019F) and a reverse primer complementary to intron 8 (IN8R:5'ataagcttggagagagaagccacgatgc3'). Digestion of the PCR product with SstII (Bethesda Research Laboratories, Gaithersburg, MD) or NaeI (Boehringer Mannheim GmbH, Mannheim, FRG) was performed as described by the manufacturers. NaeI recognizes the sequence 5'GCCGGC 3'. The PCR product was extracted with phenol, CHC13, then ethanol-precipitated before digestion, and stained with ethidium bromide after electrophoresis in a 3% agarose gel. Aliquots were cloned in Ml 3 and sequenced on both strands. Additional amplifications were performed using IN8R and a more 5'exonic forward primer (951 F:5'ttgaattctttgggaacctgtccacg3'); SstII and NaeI digestion, as well as M 13 sequencing of this PCR product yielded the same results. A 350-bp fragment containing the intron 8 / exon 9 junction was amplified using a forward primer complementary to the 3'region ofintron 8 (IN8F:5'tagaattcgcaagaaggcatttctgg3') and the reverse primer complementary to exon 9 (1558R).
The PCR product was cloned in M 13 and sequenced on both strands. An additional amplification product spanning the intron 8/exon 9 junction was obtained using 1558R and a more 3' intronic forward primer (IN8Fd:5'atgaattcgaggcgaccctcctctgg3'); it was cloned in Ml 3 and sequenced on both strands, and yielded the same results.
Results
Organification defect and normal expression of the TG gene. (Fig. 2 A) . In addition, two point mutations were found by comparison with published sequences ( 10, 11, 14, 19) (Fig. 2 A; coordinates as in reference 19) . All sequences from the total PCR product showed identical mutations (five clones sequenced). Homozygosity was further demonstrated by the complete digestion of the uncloned PCR product with NaeI (Fig. 2 B) . This enzyme recognizes specifically the mutated sequence. The specificity of the major PCR amplification product is indicated by the SstII digestion that generates the expected restriction bands. Also shown in Fig. 2 A, is the absence of mutation in the region spanning the 3' splice site of intron 8. This region was investigated in search of a mutation causing a splicing error (e.g., a mutation affect-Discussion ing the 3' acceptor splice site in intron 8) that could have explained the alternative splicing (20) .
To the best of Fig. 3 shows the expected effects of the mutation and of scribe in this st alternative splicing on the primary structure of the TPO pro-TPO mutation tein. Normal splicing ofthe mutated transcript would generate consistent with a polypeptide less than half the length of normal TPO, with activity results mutation of the proximal-and deletion of the distal-putathyroidism, an( tive heme-binding histidine residues ( 12 Gas: (24) .
As no other observations of naturally occurring TPO gene mutation have been reported, it is difficult to speculate on the nature of the additional point mutations found in our patient. They may have accumulated because of lack of selective pressure on the abnormal gene. Alternatively, although they induce a change in amino acids (11157:G -> T:Ala --Ser and 1237:G --C:Ser --Thr in the reading frame of the normal allele) they may represent polymorphisms that were present before the GGCC duplication; these point mutations are however not found in any of the four independently published sequences ( 11, 1 14, 19) .
From a practical viewpoint, the presence ofthe NaeI site in the TPO alleles amplified by PCR as described in Methods provides a rapid test for direct genetic diagnosis of this mutation. Considering the expected genetic heterogeneity of organification defects, analysis of further cases will provide new insight on the structure-function relationships ofthyroid peroxi- 
